Effects of Four-Week Rhodiola Rosea Supplementation on Physical Fitness, Neuromuscular Performance, and Decision-Making in Competitive Football Players
1 other identifier
interventional
24
1 country
1
Brief Summary
This study investigates whether four weeks of Rhodiola rosea supplementation can improve physical fitness, neuromuscular performance, and decision-making ability in competitive male football players. Participants are randomly assigned to receive either Rhodiola rosea or a placebo while continuing their regular football training. Before and after the four-week intervention, all participants complete a series of tests, including aerobic fitness, repeated sprint ability, jumping performance, reaction time, and soccer-specific decision-making tasks. Blood samples are also collected to assess fatigue and recovery-related markers. The purpose of this study is to determine whether Rhodiola rosea supplementation can enhance performance and cognitive function under high-intensity training and competition conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 4, 2025
CompletedFirst Submitted
Initial submission to the registry
January 9, 2026
CompletedFirst Posted
Study publicly available on registry
January 26, 2026
CompletedJanuary 26, 2026
January 1, 2026
28 days
January 9, 2026
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Yo-Yo Intermittent Recovery Test Level 2 (Yo-Yo IR2) distance
The Yo-Yo Intermittent Recovery Test Level 2 (Yo-Yo IR2) will be used to assess high-intensity intermittent endurance capacity. The total distance completed during the test will be recorded at baseline and after 4 weeks of Rhodiola rosea or placebo supplementation.
Time Frame: Baseline and Week 4
Secondary Outcomes (10)
Best sprint time during repeated sprint test
Time Frame: Baseline and Week 4
Mean sprint time during repeated sprint test
Baseline and Week 4
Countermovement jump (CMJ) height
Time Frame: Baseline and Week 4
Decision-making reaction time
Time Frame: Baseline and Week 4
Blood lactate concentration immediately post-repeated sprint exercise
Baseline and Week 4 (immediately post-repeated sprint exercise)
- +5 more secondary outcomes
Study Arms (2)
Rhodiola rosea Group
EXPERIMENTALParticipants received Rhodiola rosea supplementation for 4 weeks in addition to their regular football training.
Placebo
PLACEBO COMPARATORParticipants consumed placebo capsules identical in appearance to Rhodiola rosea for 4 weeks.
Interventions
Participants assigned to this intervention will receive Rhodiola rosea extract for 4 weeks in addition to their regular football training. The supplement will be administered orally in capsule form at a dose of 2,400 mg per day, given twice daily. The extract is standardized to salidroside, providing a total of 12 mg salidroside per daily dose. The capsules contain starch as excipient and gelatin as the capsule shell. All supplements are sourced from the same production batch to ensure consistency throughout the intervention period. Adherence will be monitored by capsule count and compliance logs.
Participants assigned to this intervention will receive placebo capsules identical in appearance, taste, and packaging to the Rhodiola rosea capsules for 4 weeks in addition to their regular football training. The placebo contains inert ingredients and is administered orally following the same dosing schedule as the Rhodiola rosea group.
Eligibility Criteria
You may qualify if:
- Male competitive football players aged 18-30 years
- Regular participation in structured football training (≥3 sessions per week)
- Free from musculoskeletal injury for at least 3 months prior to the study
- Not using any nutritional supplements or ergogenic aids for at least 4 weeks before enrollment
- Willing to maintain habitual diet and training throughout the study
- Provided written informed consent
You may not qualify if:
- History of cardiovascular, metabolic, neurological, or endocrine disease
- Use of Rhodiola rosea, caffeine, or other performance-enhancing supplements within the past 4 weeks
- Current smoking or substance abuse
- Known allergy to herbal supplements
- Any injury or illness that could affect physical performance or safe participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
China Football Institute, Beijing Sport University
Beijing, Beijing Municipality, 100084, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dingmeng Ren, PhD
Beijing Sport University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Both participants and outcome assessors were blinded to group allocation. Supplements and placebo were identical in appearance and packaging.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Graduate Student
Study Record Dates
First Submitted
January 9, 2026
First Posted
January 26, 2026
Study Start
August 30, 2025
Primary Completion
September 27, 2025
Study Completion
October 4, 2025
Last Updated
January 26, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to participant confidentiality and institutional data protection policies.